Journal of Molecular and Cellular Cardiology
Volume 49, Issue 4 , Pages 655-663 , October 2010

EMMPRIN activates multiple transcription factors in cardiomyocytes, and induces interleukin-18 expression via Rac1-dependent PI3K/Akt/IKK/NF-κB andMKK7/JNK/AP-1 signaling

  • Balachandar Venkatesan

      Affiliations

    • Research Service, Southeast Louisiana Veterans Health Care System, New Orleans, LA 70161, USA
    • Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA 70112, USA
    • ,
  • Anthony J. Valente

      Affiliations

    • Department of Medicine, University of Texas Health Science Center, San Antonio, TX 78229, USA
    • ,
  • Sumanth D. Prabhu

      Affiliations

    • Institute of Molecular Cardiology, Department of Medicine, University of Louisville, Louisville, KY 40292, USA
    • Medical Service, Louisville Veterans Affairs Medical Center, Louisville, KY 40206, USA
    • ,
  • Prakashsrinivasan Shanmugam

      Affiliations

    • Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA 70112, USA
    • ,
  • Patrice Delafontaine

      Affiliations

    • Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA 70112, USA
    • ,
  • Bysani Chandrasekar

      Affiliations

    • Research Service, Southeast Louisiana Veterans Health Care System, New Orleans, LA 70161, USA
    • Heart and Vascular Institute, Tulane University School of Medicine, New Orleans, LA 70112, USA
    • Corresponding Author InformationCorresponding author. Heart and Vascular Institute, Tulane University School of Medicine, 1430 Tulane Avenue, SL-48, New Orleans, LA 70112, USA. Tel.: +1 504 988 3034; fax: +1 504 988 4237.

Received 6 April 2010 ,Revised 17 May 2010 ,Accepted 20 May 2010.

References 

  1. Li YY, McTiernan CF, Feldman AM. Interplay of matrix metalloproteinases, tissue inhibitors of metalloproteinases and their regulators in cardiac matrix remodeling. Cardiovasc. Res. May 2000;46(2):214–224
  2. Huet E, Gabison EE, Mourah S, Menashi S. Role of emmprin/CD147 in tissue remodeling. Connect. Tissue Res. 2008;49(3):175–179
  3. Iacono KT, Brown AL, Greene MI, Saouaf SJ. CD147 immunoglobulin superfamily receptor function and role in pathology. Exp. Mol. Pathol. Dec 2007;83(3):283–295
  4. Sun J, Hemler ME. Regulation of MMP-1 and MMP-2 production through CD147/extracellular matrix metalloproteinase inducer interactions. Cancer Res. Mar 1 2001;61(5):2276–2281
  5. Tang Y, Kesavan P, Nakada MT, Yan L. Tumor–stroma interaction: positive feedback regulation of extracellular matrix metalloproteinase inducer (EMMPRIN) expression and matrix metalloproteinase-dependent generation of soluble EMMPRIN. Mol. Cancer Res. Feb 2004;2(2):73–80
  6. Igakura T, Kadomatsu K, Kaname T, Muramatsu H, Fan QW, Miyauchi T, et al. A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis. Dev. Biol. Feb 15 1998;194(2):152–165
  7. Kuno N, Kadomatsu K, Fan QW, Hagihara M, Senda T, Mizutani S, et al. Female sterility in mice lacking the basigin gene, which encodes a transmembrane glycoprotein belonging to the immunoglobulin superfamily. FEBS Lett. Mar 27 1998;425(2):191–194
  8. Schmidt R, Bultmann A, Ungerer M, Joghetaei N, Bulbul O, Thieme S, et al. Extracellular matrix metalloproteinase inducer regulates matrix metalloproteinase activity in cardiovascular cells: implications in acute myocardial infarction. Circulation. Feb 14 2006;113(6):834–841
  9. Schmidt R, Bultmann A, Fischel S, Gillitzer A, Cullen P, Walch A, et al. Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes. Circ. Res. Feb 15 2008;102(3):302–309
  10. Venkatesan B, Valente AJ, Reddy VS, Siwik DA, Chandrasekar B. Resveratrol blocks interleukin-18-EMMPRIN cross-regulation and smooth muscle cell migration. Am. J. Physiol. Heart Circ. Physiol. Aug 2009;297(2):H874–H886
  11. Siwik DA, Kuster GM, Brahmbhatt JV, Zaidi Z, Malik J, Ooi H, et al. EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes. J. Mol. Cell. Cardiol. Jan 2008;44(1):210–217
  12. Fielitz J, Leuschner M, Zurbrugg HR, Hannack B, Pregla R, Hetzer R, et al. Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis. J. Mol. Med. Dec 2004;82(12):809–820
  13. Spinale FG, Coker ML, Heung LJ, Bond BR, Gunasinghe HR, Etoh T, et al. A matrix metalloproteinase induction/activation system exists in the human left ventricular myocardium and is upregulated in heart failure. Circulation. Oct 17 2000;102(16):1944–1949
  14. Zavadzkas JA, Plyler RA, Bouges S, Koval CN, Rivers WT, Beck CU, et al. Cardiac-restricted overexpression of extracellular matrix metalloproteinase inducer causes myocardial remodeling and dysfunction in aging mice. Am. J. Physiol. Heart Circ. Physiol. Oct 2008;295(4):H1394–H1402
  15. Dinarello CA, Novick D, Puren AJ, Fantuzzi G, Shapiro L, Muhl H, et al. Overview of interleukin-18: more than an interferon-gamma inducing factor. J. Leukoc. Biol. Jun 1998;63(6):658–664
  16. Zabalgoitia M, Colston JT, Reddy SV, Holt JW, Regan RF, Stec DE, et al. Carbon monoxide donors or heme oxygenase-1 (HO-1) overexpression blocks interleukin-18-mediated NF-kappaB-PTEN-dependent human cardiac endothelial cell death. Free Radic. Biol. Med. Feb 1 2008;44(3):284–298
  17. Chandrasekar B, Mummidi S, Valente AJ, Patel DN, Bailey SR, Freeman GL, et al. The pro-atherogenic cytokine interleukin-18 induces CXCL16 expression in rat aortic smooth muscle cells via MyD88, interleukin-1 receptor-associated kinase, tumor necrosis factor receptor-associated factor 6, c-Src, phosphatidylinositol 3-kinase, Akt, c-Jun N-terminal kinase, and activator protein-1 signaling. J. Biol. Chem. Jul 15 2005;280(28):26263–26277
  18. Yu Q, Vazquez R, Khojeini EV, Patel C, Venkataramani R, Larson DF. IL-18 induction of osteopontin mediates cardiac fibrosis and diastolic dysfunction in mice. Am. J. Physiol. Heart Circ. Physiol. Jul 2009;297(1):H76–H85
  19. Chandrasekar B, Mummidi S, Claycomb WC, Mestril R, Nemer M. Interleukin-18 is a pro-hypertrophic cytokine that acts through a phosphatidylinositol 3-kinase-phosphoinositide-dependent kinase-1-Akt-GATA4 signaling pathway in cardiomyocytes. J. Biol. Chem. Feb 11 2005;280(6):4553–4567
  20. Venkatachalam K, Prabhu SD, Reddy VS, Boylston WH, Valente AJ, Chandrasekar B. Neutralization of interleukin-18 ameliorates ischemia/reperfusion-induced myocardial injury. J. Biol. Chem. Mar 20 2009;284(12):7853–7865
  21. Colston JT, Boylston WH, Feldman MD, Jenkinson CP, de la Rosa SD, Barton A, et al. Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload. Biochem. Biophys. Res. Commun. Mar 9 2007;354(2):552–558
  22. Wang M, Tan J, Wang Y, Meldrum KK, Dinarello CA, Meldrum DR. IL-18 binding protein-expressing mesenchymal stem cells improve myocardial protection after ischemia or infarction. Proc. Natl. Acad. Sci. U. S. A. Oct 13 2009;106(41):17499–17504
  23. Mallat Z, Heymes C, Corbaz A, Logeart D, Alouani S, Cohen-Solal A, et al. Evidence for altered interleukin 18 (IL)-18 pathway in human heart failure. FASEB J. Nov 2004;18(14):1752–1754
  24. Venkatesan B, Prabhu SD, Venkatachalam K, Mummidi S, Valente AJ, Clark RA, et al. WNT1-inducible signaling pathway protein-1 activates diverse cell survival pathways and blocks doxorubicin-induced cardiomyocyte death. Cell Signal. May 22 2010;626(5):809–820
  25. Imam SZ, Jankovic J, Ali SF, Skinner JT, Xie W, Conneely OM, et al. Nitric oxide mediates increased susceptibility to dopaminergic damage in Nurr1 heterozygous mice. FASEB J. Sep 2005;19(11):1441–1450
  26. Benotmane AM, Hoylaerts MF, Collen D, Belayew A. Nonisotopic quantitative analysis of protein–DNA interactions at equilibrium. Anal. Biochem. Aug 1 1997;250(2):181–185
  27. Chandrasekar B, Marelli-Berg FM, Tone M, Bysani S, Prabhu SD, Murray DR. Beta-adrenergic stimulation induces interleukin-18 expression via beta2-AR, PI3K, Akt, IKK, and NF-kappaB. Biochem. Biophys. Res. Commun. Jun 25 2004;319(2):304–311
  28. Tone M, Thompson SA, Tone Y, Fairchild PJ, Waldmann H. Regulation of IL-18 (IFN-gamma-inducing factor) gene expression. J. Immunol. Dec 15 1997;159(12):6156–6163
  29. Mollen KP, McCloskey CA, Tanaka H, Prince JM, Levy RM, Zuckerbraun BS, et al. Hypoxia activates c-Jun N-terminal kinase via Rac1-dependent reactive oxygen species production in hepatocytes. Shock. Sep 2007;28(3):270–277
  30. Sawada N, Li Y, Liao JK. Novel aspects of the roles of Rac1 GTPase in the cardiovascular system. Curr. Opin. Pharmacol. Apr 2010;10(2):116–121
  31. Satoh M, Ogita H, Takeshita K, Mukai Y, Kwiatkowski DJ, Liao JK. Requirement of Rac1 in the development of cardiac hypertrophy. Proc. Natl. Acad. Sci. U. S. A. May 9 2006;103(19):7432–7437
  32. Tournier C, Dong C, Turner TK, Jones SN, Flavell RA, Davis RJ. MKK7 is an essential component of the JNK signal transduction pathway activated by proinflammatory cytokines. Genes Dev. Jun 1 2001;15(11):1419–1426
  33. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat. Rev. Mol. Cell Biol. Aug 2001;2(8):599–609
  34. Spooren A, Kooijman R, Lintermans B, Van Craenenbroeck K, Vermeulen L, Haegeman G, et al. Cooperation of NFkappaB and CREB to induce synergistic IL-6 expression in astrocytes. Cell Signal. May 2010;22(5):871–881
  35. van Dam H, Castellazzi M. Distinct roles of Jun:Fos and Jun:ATF dimers in oncogenesis. Oncogene. Apr 30 2001;20(19):2453–2464
  36. Whitmarsh AJ, Davis RJ. Transcription factor AP-1 regulation by mitogen-activated protein kinase signal transduction pathways. J. Mol. Med. Oct 1996;74(10):589–607
  37. Hordijk PL. Regulation of NADPH oxidases: the role of Rac proteins. Circ. Res. Mar 3 2006;98(4):453–462
  38. Byun JY, Yoon CH, An S, Park IC, Kang CM, Kim MJ, et al. The Rac1/MKK7/JNK pathway signals upregulation of Atg5 and subsequent autophagic cell death in response to oncogenic Ras. Carcinogenesis. Nov 2009;30(11):1880–1888
  39. Yan C, Boyd DD. Regulation of matrix metalloproteinase gene expression. J. Cell. Physiol. Apr 2007;211(1):19–26
  40. Chandrasekar B, Mummidi S, Mahimainathan L, Patel DN, Bailey SR, Imam SZ, et al. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J. Biol. Chem. Jun 2 2006;281(22):15099–15109
  41. Kim H, Pennie WD, Sun Y, Colburn NH. Differential functional significance of AP-1 binding sites in the promoter of the gene encoding mouse tissue inhibitor of metalloproteinases-3. Biochem. J. Jun 1 1997;324(Pt 2):547–553
  42. Clark IM, Rowan AD, Edwards DR, Bech-Hansen T, Mann DA, Bahr MJ, et al. Transcriptional activity of the human tissue inhibitor of metalloproteinases 1 (TIMP-1) gene in fibroblasts involves elements in the promoter, exon 1 and intron 1. Biochem. J. Jun 1 1997;324(Pt 2):611–617
  43. Wang Y, Su B, Sah VP, Brown JH, Han J, Chien KR. Cardiac hypertrophy induced by mitogen-activated protein kinase kinase 7, a specific activator for c-Jun NH2-terminal kinase in ventricular muscle cells. J. Biol. Chem. Mar 6 1998;273(10):5423–5426
  44. Lim JY, Park SJ, Hwang HY, Park EJ, Nam JH, Kim J, et al. TGF-beta1 induces cardiac hypertrophic responses via PKC-dependent ATF-2 activation. J. Mol. Cell. Cardiol. Oct 2005;39(4):627–636
  45. Yu Q, Stamenkovic I. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis. Genes Dev. Jan 15 2000;14(2):163–176
  46. Woldbaek PR, Sande JB, Stromme TA, Lunde PK, Djurovic S, Lyberg T, et al. Daily administration of interleukin-18 causes myocardial dysfunction in healthy mice. Am. J. Physiol. Heart Circ. Physiol. Aug 2005;289(2):H708–H714
  47. Boengler K, Hilfiker-Kleiner D, Drexler H, Heusch G, Schulz R. The myocardial JAK/STAT pathway: from protection to failure. Pharmacol. Ther. Nov 2008;120(2):172–185
  48. Heusch G, Boengler K, Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria. Circulation. Nov 4 2008;118(19):1915–1919

PII: S0022-2828(10)00208-7

doi: 10.1016/j.yjmcc.2010.05.007

Journal of Molecular and Cellular Cardiology
Volume 49, Issue 4 , Pages 655-663 , October 2010

Article Tools

* Image Usage & Resolution